• Find an Expert
  • Search iconSearch
  • Menu
  • Help
  • Report an issue

Book Chapter

Role of cell quiescence in glioblastoma cytotoxic resistance and strategies for therapeutic intervention

Ryan J Atkins, Stanley S Stylli, Niall M Corcoran, Christopher M Hovens, Theo Mantamadiotis

Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies | Elsevier | Published : 2021

DOI: 10.1016/b978-0-12-821567-8.00003-8

University of Melbourne Researchers

Christopher Hovens's Profile Picture
Christopher Hovens Author Surgery - Royal Melbourne Hospital

Stanley Stylli's Profile Picture
Stanley Stylli Author Surgery - Royal Melbourne Hospital

Niall Corcoran's Profile Picture
Niall Corcoran Author Surgery - Royal Melbourne Hospital

Theo Mantamadiotis's Profile Picture
Theo Mantamadiotis Author Microbiology and Immunology

Related Projects (2)

Project icon

Determining the origin of lethal metastases in multifocal primary prostate cancer

New biomarkers are required to accurately predict lethal prostate cancer from benign, indolent disaese that doesn't require expensive treatm..

Project icon

TRACKING THE ORIGINS AND DRIVERS OF METASTASIS IN PROSTATE CANCER

Prostate cancer is now the most commonly diagnosed cancer but only 10% of men with it, will die from it. Our current ability to discriminate..

Grants

Keywords

Brain Cancer
Rare Diseases
Brain Disorders
Stem Cell Research - Nonembryonic - Human
Stem Cell Research - Nonembryonic - Non-Human
Cancer
Stem Cell Research

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  ›

About us  

›

Careers at Melbourne  

›

Safety and respect  

›

Newsroom  

›

Contact  

›

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  ›
facebookIcontwitterIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224